OBJECTIVES: To compare magnetic resonance and ultrasound imaging for uterine fibroid measurement. STUDY DESIGN:Eighteen women undergoinghysterectomy for symptomatic fibroids underwent preoperative pelvic ultrasound and magnetic resonance imaging. Resected fibroids were correlated with the images. Weighted kappa agreement statistics and Spearman correlations for patient characteristics were calculated. RESULTS: Magnetic resonance imaging identified 121 of 151 pathologically confirmed fibroids, yielding 91% positive predictive value (95% confidence interval [CI], 85-95) and 80% sensitivity (95% CI, 73-86). Positive predictive value and sensitivity for ultrasound were 97% (95% CI, 89-100) and 40% (95% CI, 32-48), respectively. Mean diameter-equivalent discrepancies between imaging and pathologic measurements were 0.51 +/- 0.68 cm for magnetic resonance imaging and 0.76 +/- 0.88 cm for ultrasound. kappa statistics comparing imaging to pathology showed better agreement for magnetic resonance than ultrasound (kappa = 0.60 vs 0.36). The number of fibroids detected by magnetic resonance imaging predicted measurement errors (r = 0.76; P = .0002). CONCLUSION: Superior sensitivity and minimal measurement discrepancies suggest magnetic resonance imaging may be preferentially used for fibroid assessment in clinical research.
RCT Entities:
OBJECTIVES: To compare magnetic resonance and ultrasound imaging for uterine fibroid measurement. STUDY DESIGN: Eighteen women undergoing hysterectomy for symptomatic fibroids underwent preoperative pelvic ultrasound and magnetic resonance imaging. Resected fibroids were correlated with the images. Weighted kappa agreement statistics and Spearman correlations for patient characteristics were calculated. RESULTS: Magnetic resonance imaging identified 121 of 151 pathologically confirmed fibroids, yielding 91% positive predictive value (95% confidence interval [CI], 85-95) and 80% sensitivity (95% CI, 73-86). Positive predictive value and sensitivity for ultrasound were 97% (95% CI, 89-100) and 40% (95% CI, 32-48), respectively. Mean diameter-equivalent discrepancies between imaging and pathologic measurements were 0.51 +/- 0.68 cm for magnetic resonance imaging and 0.76 +/- 0.88 cm for ultrasound. kappa statistics comparing imaging to pathology showed better agreement for magnetic resonance than ultrasound (kappa = 0.60 vs 0.36). The number of fibroids detected by magnetic resonance imaging predicted measurement errors (r = 0.76; P = .0002). CONCLUSION: Superior sensitivity and minimal measurement discrepancies suggest magnetic resonance imaging may be preferentially used for fibroid assessment in clinical research.
Authors: Eric D Levens; Clariss Potlog-Nahari; Alicia Y Armstrong; Robert Wesley; Ahalya Premkumar; Diana L Blithe; Wendy Blocker; Lynnette K Nieman Journal: Obstet Gynecol Date: 2008-05 Impact factor: 7.661
Authors: Donna D Baird; Stacy A Patchel; Tina M Saldana; David M Umbach; Tracy Cooper; Ganesa Wegienka; Quaker E Harmon Journal: Am J Obstet Gynecol Date: 2020-02-24 Impact factor: 8.661
Authors: Sarah R Hoffman; Anissa I Vines; Jacqueline R Halladay; Emily Pfaff; Lauren Schiff; Daniel Westreich; Aditi Sundaresan; La-Shell Johnson; Wanda K Nicholson Journal: Am J Obstet Gynecol Date: 2018-02-09 Impact factor: 8.661
Authors: Ami R Zota; Ruth J Geller; Antonia M Calafat; Cherie Q Marfori; Andrea A Baccarelli; Gaby N Moawad Journal: Fertil Steril Date: 2018-11-15 Impact factor: 7.329
Authors: Michael J Bray; Melissa F Wellons; Sarah H Jones; Eric S Torstenson; Todd L Edwards; Digna R Velez Edwards Journal: Fertil Steril Date: 2018-09 Impact factor: 7.490
Authors: Elizabeth A Pritts; David J Vanness; Jonathan S Berek; William Parker; Ronald Feinberg; Jacqueline Feinberg; David L Olive Journal: Gynecol Surg Date: 2015-05-19